{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:49:42Z","timestamp":1791607782949,"version":"4.3.4"},"reference-count":47,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,10,8]]},"DOI":"10.1248\/bpb.b26-00351","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:12:17Z","timestamp":1791411137000},"page":"1631-1640","source":"Crossref","is-referenced-by-count":0,"title":["Influence of Hepatocellular Senescence on Serum Amyloid A Expression and Response to Proinflammatory Cytokines under Steatotic Conditions"],"prefix":"10.1248","volume":"49","author":[{"given":"Toru","family":"Takarada","sequence":"first","affiliation":[{"name":"Laboratory of Functional Molecular Chemistry, Kobe Pharmaceutical University, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Molecular Chemistry, Kobe Pharmaceutical University, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Omura","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Molecular Chemistry, Kobe Pharmaceutical University, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Jichi Medical University, Shimotsuke, Tochigi 329\u20130498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Molecular Chemistry, Kobe Pharmaceutical University, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Betts JC, Edbrooke MR, Thakker RV, Woo P. The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. <i>Scand. J. Immunol.<\/i>, <b>34<\/b>, 471\u2013482 (1991).","DOI":"10.1111\/j.1365-3083.1991.tb01570.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Webb NR. High-density lipoproteins and serum amyloid A (SAA). <i>Curr. Atheroscler. Rep.<\/i>, <b>23<\/b>, 7 (2021).","DOI":"10.1007\/s11883-020-00901-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. <i>Eur. J. Biochem.<\/i>, <b>265<\/b>, 501\u2013523 (1999).","DOI":"10.1046\/j.1432-1327.1999.00657.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. <i>Adv. Immunol.<\/i>, <b>34<\/b>, 141\u2013212 (1983).","DOI":"10.1016\/S0065-2776(08)60379-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) de Beer MC, Yuan T, Kindy MS, Asztalos BF, Roheim PS, de Beer FC. Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. <i>J. Lipid Res.<\/i>, <b>36<\/b>, 526\u2013534 (1995).","DOI":"10.1016\/S0022-2275(20)39886-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yamada T, Miida T, Itoh Y, Kawai T, Benson MD. Characterization of serum amyloid A4 as a plasma apolipoprotein. <i>Clin. Chim. Acta<\/i>, <b>251<\/b>, 105\u2013112 (1996).","DOI":"10.1016\/0009-8981(96)06296-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Takarada T, Fujinaka R, Shimada M, Fukuda M, Yamada T, Tanaka M. Effect of N-glycosylation on secretion, degradation and lipoprotein distribution of human serum amyloid A4. <i>Biochim. Biophys. Acta Mol. Cell Biol. Lipids<\/i>, <b>1870<\/b>, 159588 (2025).","DOI":"10.1016\/j.bbalip.2024.159588"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Savinova OV, Fillaus K, Jing L, Harris WS, Shearer GC. Reduced apolipoprotein glycosylation in patients with the metabolic syndrome. <i>PLOS ONE<\/i>, <b>9<\/b>, e104833 (2014).","DOI":"10.1371\/journal.pone.0104833"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Meng H, Ruan J, Chen Y, Yan Z, Shi K, Li X, Yang P, Meng F. Investigation of specific proteins related to different types of coronary atherosclerosis. <i>Front. Cardiovasc. Med.<\/i>, <b>8<\/b>, 758035 (2021).","DOI":"10.3389\/fcvm.2021.758035"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Irvine KM, Skoien R, Bokil NJ, Melino M, Thomas GP, Loo D, Gabrielli B, Hill MM, Sweet MJ, Clouston AD, Powell EE. Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration. <i>World J. Gastroenterol.<\/i>, <b>20<\/b>, 17851\u201317862 (2014).","DOI":"10.3748\/wjg.v20.i47.17851"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Campisi J, d\u2019Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>8<\/b>, 729\u2013740 (2007).","DOI":"10.1038\/nrm2233"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Copp\u00e9 JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. <i>Annu. Rev. Pathol.<\/i>, <b>5<\/b>, 99\u2013118 (2010).","DOI":"10.1146\/annurev-pathol-121808-102144"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Acosta JC, Banito A, Wuestefeld T, <i>et al<\/i>. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. <i>Nat. Cell Biol.<\/i>, <b>15<\/b>, 978\u2013990 (2013).","DOI":"10.1038\/ncb2784"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ogrodnik M, Miwa S, Tchkonia T, Tiniakos D, Wilson CL, Lahat A, Day CP, Burt A, Palmer A, Anstee QM, Grellscheid SN, Hoeijmakers JHJ, Barnhoorn S, Mann DA, Bird TG, Vermeij WP, Kirkland JL, Passos JF, von Zglinicki T, Jurk D. Cellular senescence drives age-dependent hepatic steatosis. <i>Nat. Commun.<\/i>, <b>8<\/b>, 15691 (2017).","DOI":"10.1038\/ncomms15691"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Bonnet L, Alexandersson I, Baboota RK, Kroon T, Oscarsson J, Smith U, Boucher J. Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH. <i>Front. Endocrinol.<\/i>, <b>13<\/b>, 957616 (2022).","DOI":"10.3389\/fendo.2022.957616"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. <i>J. Obes. Metab. Syndr.<\/i>, <b>32<\/b>, 197\u2013213 (2023).","DOI":"10.7570\/jomes23052"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Baboota RK, Rawshani A, Bonnet L, Li X, Yang H, Mardinoglu A, Tchkonia T, Kirkland JL, Hoffmann A, Dietrich A, Boucher J, Bluher M, Smith U. BMP4 and gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD\/NASH. <i>Nat. Metab.<\/i>, <b>4<\/b>, 1007\u20131021 (2022).","DOI":"10.1038\/s42255-022-00620-x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Jiang B, Wang D, Hu Y, Li W, Liu F, Zhu X, Li X, Zhang H, Bai H, Yang Q, Yang X, Ben J, Chen Q. Serum amyloid A1 exacerbates hepatic steatosis <i>via<\/i> TLR4-mediated NF-kappaB signaling pathway. <i>Mol. Metab.<\/i>, <b>59<\/b>, 101462 (2022).","DOI":"10.1016\/j.molmet.2022.101462"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Li D, Xie P, Zhao S, Zhao J, Yao Y, Zhao Y, Ren G, Liu X. Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>555<\/b>, 54\u201360 (2021).","DOI":"10.1016\/j.bbrc.2021.02.124"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yuan ZY, Zhang XX, Wu YJ, Zeng ZP, She WM, Chen SY, Zhang YQ, Guo JS. Serum amyloid A levels in patients with liver diseases. <i>World J. Gastroenterol.<\/i>, <b>25<\/b>, 6440\u20136450 (2019).","DOI":"10.3748\/wjg.v25.i43.6440"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kumar P, Hassan M, Tacke F, Engelmann C. Delineating the heterogeneity of senescence-induced-functional alterations in hepatocytes. <i>Cell. Mol. Life Sci.<\/i>, <b>81<\/b>, 200 (2024).","DOI":"10.1007\/s00018-024-05230-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kciuk M, Gielecinska A, Mujwar S, Kolat D, Kaluzinska-Kolat Z, Celik I, Kontek R. Doxorubicin-an agent with multiple mechanisms of anticancer activity. <i>Cells<\/i>, <b>12<\/b>, 659 (2023).","DOI":"10.3390\/cells12040659"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Mijit M, Caracciolo V, Melillo A, Amicarelli F, Giordano A. Role of p53 in the regulation of cellular senescence. <i>Biomolecules<\/i>, <b>10<\/b>, 420 (2020).","DOI":"10.3390\/biom10030420"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yamada T, Sato J, Kotani K, Tanaka M. Influence of polymorphism on glycosylation of serum amyloid A4 protein. <i>Biochem. Res. Int.<\/i>, <b>2014<\/b>, 527254 (2014).","DOI":"10.1155\/2014\/527254"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Levy G, Cohen M, Nahmias Y. <i>In vitro<\/i> cell culture models of hepatic steatosis. <i>Methods Mol. Biol.<\/i>, <b>1250<\/b>, 377\u2013390 (2015).","DOI":"10.1007\/978-1-4939-2074-7_29"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) da Cruz NS, Pasquarelli-do-Nascimento G, e Oliveira ACP, Magalh\u00e3es KG. Inflammasome-mediated cytokines: a key connection between obesity-associated NASH and liver cancer progression. <i>Biomedicines<\/i>, <b>10<\/b>, 2344 (2022).","DOI":"10.3390\/biomedicines10102344"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Steel DM, Sellar GC, Uhlar CM, Simon S, DeBeer FC, Whitehead AS. A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2). <i>Genomics<\/i>, <b>16<\/b>, 447\u2013454 (1993).","DOI":"10.1006\/geno.1993.1209"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Mohanty T, Milicevic K, Gothert H, Tillmann A, Padra M, Papareddy P, Herwald H. Balancing inflammation: the specific roles of serum amyloid A proteins in sterile and infectious diseases. <i>Front. Immunol.<\/i>, <b>16<\/b>, 1544085 (2025).","DOI":"10.3389\/fimmu.2025.1544085"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Jumeau C, Awad F, Assrawi E, Cobret L, Duquesnoy P, Giurgea I, Valeyre D, Grateau G, Amselem S, Bernaudin JF, Karabina SA. Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages. <i>PLOS ONE<\/i>, <b>14<\/b>, e0217005 (2019).","DOI":"10.1371\/journal.pone.0217005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Zhang Z, Wang J, Li H, Niu Q, Tao Y, Zhao X, Zeng Z, Dong H. The role of the interleukin family in liver fibrosis. <i>Front. Immunol.<\/i>, <b>16<\/b>, 1497095 (2025).","DOI":"10.3389\/fimmu.2025.1497095"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Steel DM, Whitehead AS. Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-1 beta and interleukin-6 in the human hepatoma cell line PLC\/PRF\/5. <i>Biochem. J.<\/i>, <b>277<\/b>, 477\u2013482 (1991).","DOI":"10.1042\/bj2770477"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ganapathi MK, May LT, Schultz D, Brabenec A, Weinstein J, Sehgal PB, Kushner I. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>157<\/b>, 271\u2013277 (1988).","DOI":"10.1016\/S0006-291X(88)80043-3"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Lee TK, Lau TC, Ng IO. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. <i>Cancer Chemother. Pharmacol.<\/i>, <b>49<\/b>, 78\u201386 (2002).","DOI":"10.1007\/s00280-001-0376-4"},{"key":"34","unstructured":"34) Demaria M, O\u2019Leary MN, Chang J, <i>et al<\/i>. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. <i>Cancer Discov.<\/i>, <b>7<\/b>, 165\u2013176 (2017)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Salotti J, Johnson PF. Regulation of senescence and the SASP by the transcription factor C\/EBP\u03b2. <i>Exp. Gerontol.<\/i>, <b>128<\/b>, 110752 (2019).","DOI":"10.1016\/j.exger.2019.110752"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Rossmann C, Windpassinger C, Brunner D, Kovacevic A, Schweighofer N, Malli R, Schuligoi R, Prokesch A, Kluve-Beckerman B, Graier WF, Kratky D, Sattler W, Malle E. Characterization of rat serum amyloid A4 (SAA4): a novel member of the SAA superfamily. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>450<\/b>, 1643\u20131649 (2014).","DOI":"10.1016\/j.bbrc.2014.07.054"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Cindri\u0107 A, Kri\u0161ti\u0107 J, Martini\u0107 Kavur M, Pezer M. Glycosylation and aging. <i>The role of glycosylation in health and disease<\/i>. (Lauc G, Trbojevi\u0107-Akma\u010di\u0107 I eds.) Springer International Publishing, Cham, Switzerland, pp. 341\u2013373 (2021).","DOI":"10.1007\/978-3-030-70115-4_17"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Guo Q, Zhang C, Wang Y. Overexpression of apolipoprotein A-I alleviates endoplasmic reticulum stress in hepatocytes. <i>Lipids Health Dis.<\/i>, <b>16<\/b>, 105 (2017).","DOI":"10.1186\/s12944-017-0497-3"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Wang Y, Zhang Y, Wang Y. Overexpression of apolipoprotein A-I alleviates insulin resistance in MASLD mice through the PPAR\u03b1 pathway. <i>Int. J. Mol. Sci.<\/i>, <b>26<\/b>, 1051 (2025). \u2039https:\/\/www.mdpi.com\/1422-0067\/26\/3\/1051\u203a.","DOI":"10.3390\/ijms26031051"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Song P, Kwon Y, Yea K, Moon HY, Yoon JH, Ghim J, Hyun H, Kim D, Koh A, Berggren PO, Suh PG, Ryu SH. Apolipoprotein a1 increases mitochondrial biogenesis through AMP-activated protein kinase. <i>Cell. Signal.<\/i>, <b>27<\/b>, 1873\u20131881 (2015).","DOI":"10.1016\/j.cellsig.2015.05.003"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Tian F, Wu CL, Yu BL, Liu L, Hu JR. Apolipoprotein O expression in mouse liver enhances hepatic lipid accumulation by impairing mitochondrial function. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>491<\/b>, 8\u201314 (2017).","DOI":"10.1016\/j.bbrc.2017.06.128"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Mladenic K, Lenartic M, Marinovic S, Polic B, Wensveen FM. The \u201cdomino effect\u201d in MASLD: the inflammatory cascade of steatohepatitis. <i>Eur. J. Immunol.<\/i>, <b>54<\/b>, e2149641 (2024).","DOI":"10.1002\/eji.202149641"},{"key":"43","unstructured":"43) Hadinia A, Doustimotlagh AH, Goodarzi HR, Arya A, Jafarinia M. Circulating levels of pro-inflammatory cytokines in patients with nonalcoholic fatty liver disease and non-alcoholic steatohepatitis. <i>Iran. J. Immunol.<\/i>, <b>16<\/b>, 327\u2013333 (2019). \u2039https:\/\/iji.sums.ac.ir\/article_45975.html\u203a."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Budamagunta V, Manohar-Sindhu S, Yang Y, He Y, Traktuev DO, Foster TC, Zhou D. Senescence-associated hyper-activation to inflammatory stimuli in vitro. <i>Aging<\/i>, <b>13<\/b>, 19088\u201319107 (2021).","DOI":"10.18632\/aging.203396"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Wilson PG, Thompson JC, Shridas P, McNamara PJ, de Beer MC, de Beer FC, Webb NR, Tannock LR. Serum amyloid A is an exchangeable apolipoprotein. <i>Arterioscler. Thromb. Vasc. Biol.<\/i>, <b>38<\/b>, 1890\u20131900 (2018).","DOI":"10.1161\/ATVBAHA.118.310979"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Green CJ, Johnson D, Amin HD, Sivathondan P, Silva MA, Wang LM, Stevanato L, McNeil CA, Miljan EA, Sinden JD, Morten KJ, Hodson L. Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line. <i>Am. J. Physiol. Endocrinol. Metab.<\/i>, <b>309<\/b>, E511\u2013E522 (2015).","DOI":"10.1152\/ajpendo.00594.2014"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. <i>Hepatology<\/i>, <b>52<\/b>, 1836\u20131846 (2010).","DOI":"10.1002\/hep.24001"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/10\/49_b26-00351\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:20:58Z","timestamp":1791606058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/10\/49_b26-00351\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00351","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"article-number":"b26-00351"}}